Literature DB >> 27750355

[Medical Treatment of Newly Arrived Refugees in Erlangen: A Study of Drug Prescription Rates Focused on Psychotropic Drugs].

Fabian Kahl1, Andreas Frewer1.   

Abstract

Background: In 2015 the number of refugees who sought asylum in Germany has increased dramatically. Therefore, the medical care for these refugees faces huge challenges. The treatment of mental illness of refugees is a particular difficult topic. Objective of this study is the acquisition of the outpatient prescriptions of drugs for newly arrived refugees in Erlangen, focused on psychotropic drugs.
Methods: Evaluation of all outpatient prescribed drugs (n=1 137), which were prescribed between 10/01/2014 and 09/30/2015 for asylum seekers living in the refugee center in Erlangen, a branch of the "Central Admission Institution" ("ZAE") Zirndorf. Funding organization of this treatment is the City of Erlangen. Settlement documents of the City of Erlangen were used for the analysis.
Results: The prescribed drugs cover the spectrum of acute primary care. Big parts of the prescription rates are antiinfectives (ATC-Code: J), medication for the respiratory system (ATC: R), as well as non-steroidal anti-inflammatory drug (NSAID's: ibuprofen, paracetamol, metamizole). The prescription of psychotropic drugs is relatively underrepresented. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27750355     DOI: 10.1055/s-0042-116325

Source DB:  PubMed          Journal:  Psychother Psychosom Med Psychol        ISSN: 0937-2032


  2 in total

1.  Disease burden in a large cohort of asylum seekers and refugees in Germany.

Authors:  Frank Müller; Evelyn Kleinert; Nele Hillermann; Anne Simmenroth; Eva Hummers; Anna Zychlinsky Scharff; Christian Dopfer; Christine Happle; Alexandra Jablonka
Journal:  J Glob Health       Date:  2021-01-30       Impact factor: 4.413

2.  Outpatient health care utilization and health expenditures of asylum seekers in Halle (Saale), Germany - an analysis of claims data.

Authors:  Andreas Niedermaier; Anna Freiberg; Daniel Tiller; Andreas Wienke; Amand Führer
Journal:  BMC Health Serv Res       Date:  2020-10-20       Impact factor: 2.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.